CT Financial Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$4.06K Hold
17
﹤0.01% 521
2016
Q4
$3.57K Hold
17
﹤0.01% 527
2016
Q3
$3.92K Hold
17
﹤0.01% 518
2016
Q2
$3.93K Sell
17
-100
-85% -$23.1K ﹤0.01% 526
2016
Q1
$31.4K Hold
117
0.02% 331
2015
Q4
$36.6K Hold
117
0.02% 326
2015
Q3
$31.8K Hold
117
0.02% 335
2015
Q2
$35.5K Sell
117
-80
-41% -$23.9K 0.02% 337
2015
Q1
$58.6K Buy
197
+17
+9% +$4.85K 0.03% 289
2014
Q4
$46.3K Buy
+180
New +$45K 0.04% 244
2014
Q1
$58.6K Buy
+197
New +$39K 0.03% 289

Other funds holding AGN

CT Financial Advisors's AGN Position: Q1 2017 in Review

CT Financial Advisors held its Allergan plc (AGN) position steady in Q1 2017 at 17 shares worth $4.06K. The position accounts for ﹤0.01% of the portfolio, ranked #521.

CT Financial Advisors first reported a position in AGN in Q1 2014 and has held it in 11 quarters since. The position peaked at $58.6K in Q1 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • CT Financial Advisors held 17 shares of Allergan plc worth $4.06K as of Q1 2017.
  • CT Financial Advisors left its Allergan plc share count unchanged in Q1 2017.
  • Allergan plc made up ﹤0.01% of CT Financial Advisors's portfolio in Q1 2017, its #521 holding.
  • CT Financial Advisors first reported a position in Allergan plc in Q1 2014 and has held it in 11 quarters since.
  • CT Financial Advisors's Allergan plc position peaked at $58.6K in Q1 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.